Generation Bio Net Tangible Assets

Generation Bio (GBIO) currently reports a net tangible assets of $51M as of September 2025. That compares with $100M in the prior-year period — down 51.6% year over year. Use the charts on this page to explore Generation Bio's net tangible assets history and peer comparisons.

Generation Bio's net tangible assets decreased from $100M to $51M — a 51.6% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Generation Bio reported $51M in net tangible assets as of September 2025. That compares with $100M in the prior-year period — down 51.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $51M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Generation Bio, and consider following GBIO for alerts when major investors trade the stock.

Generation Bio is classified in the Healthcare sector. On net tangible assets, it currently shows $51M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GBIO with unrelated industries.